Thus, the binding of HK-II to VDAC and the elevated HK-II expression contribute to the Warburg effect in cancer cells, which implies that HK-II might act as a therapeutic target for novel anticancer drug screening and design [13,14]. The gene discussed is HK2; the disease is cancer.